Max Gill

566 total citations
7 papers, 98 citations indexed

About

Max Gill is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Family Practice. According to data from OpenAlex, Max Gill has authored 7 papers receiving a total of 98 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Genetics and 1 paper in Family Practice. Recurrent topics in Max Gill's work include Diabetes Management and Research (7 papers), Diabetes Treatment and Management (4 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers). Max Gill is often cited by papers focused on Diabetes Management and Research (7 papers), Diabetes Treatment and Management (4 papers) and Hyperglycemia and glycemic control in critically ill and hospitalized patients (3 papers). Max Gill collaborates with scholars based in United States. Max Gill's co-authors include Mona Shah, Francine Kaufman, Brian K. Reilly, Megha Bansal, Robert A. Vigersky, S.P. Willman, Guy David, Steven V. Edelman, Candace Gunnarsson and Howard M. Lando and has published in prestigious journals such as Endocrine Practice, Journal of Diabetes Science and Technology and Journal of Medical Economics.

In The Last Decade

Max Gill

7 papers receiving 93 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Max Gill United States 6 81 35 24 13 12 7 98
Mikko Honkasalo Finland 6 58 0.7× 10 0.3× 15 0.6× 18 1.4× 9 0.8× 11 72
Clementina Ramos United States 5 92 1.1× 23 0.7× 23 1.0× 8 0.6× 10 0.8× 7 107
A. López-Alba France 2 60 0.7× 10 0.3× 10 0.4× 24 1.8× 6 0.5× 3 75
Anna Schranz Malta 4 69 0.9× 16 0.5× 27 1.1× 18 1.4× 5 0.4× 9 93
Sarah Biester Germany 5 81 1.0× 58 1.7× 59 2.5× 3 0.2× 7 0.6× 10 90
Terra Cushman United States 3 34 0.4× 18 0.5× 11 0.5× 6 0.5× 12 1.0× 7 55
B. Scholz Germany 4 34 0.4× 6 0.2× 6 0.3× 8 0.6× 9 0.8× 6 52
Deanna Gabrielson United States 3 31 0.4× 15 0.4× 15 0.6× 9 0.7× 5 0.4× 3 50
Muel Telo Muyer Democratic Republic of the Congo 4 34 0.4× 7 0.2× 8 0.3× 13 1.0× 3 0.3× 5 48
H. Atkins United Kingdom 3 52 0.6× 8 0.2× 7 0.3× 7 0.5× 4 0.3× 4 78

Countries citing papers authored by Max Gill

Since Specialization
Citations

This map shows the geographic impact of Max Gill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Gill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Gill more than expected).

Fields of papers citing papers by Max Gill

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Max Gill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Gill. The network helps show where Max Gill may publish in the future.

Co-authorship network of co-authors of Max Gill

This figure shows the co-authorship network connecting the top 25 collaborators of Max Gill. A scholar is included among the top collaborators of Max Gill based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max Gill. Max Gill is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Bansal, Megha, Mona Shah, Brian K. Reilly, et al.. (2018). Impact of Reducing Glycated Hemoglobin on Healthcare Costs Among a Population with Uncontrolled Diabetes. Applied Health Economics and Health Policy. 16(5). 675–684. 27 indexed citations
2.
3.
Gill, Max, et al.. (2018). Association between provider specialty and healthcare costs and glycemic control for patients with diabetes. Journal of Medical Economics. 21(7). 704–708. 5 indexed citations
4.
5.
Shah, Mona, et al.. (2017). Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data. Journal of Medical Economics. 21(3). 225–230. 30 indexed citations
6.
Garg, Satish K., Bruce W. Bode, Mark I. Friedman, et al.. (2016). Economic impact of hypoglycemia among insulin-treated patients with diabetes. Journal of Medical Economics. 19(11). 1099–1106. 5 indexed citations
7.
David, Guy, et al.. (2014). Switching from multiple daily injections to CSII pump therapy: insulin expenditures in type 2 diabetes.. PubMed. 20(11). e490–7. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mikko Honkasalo Breakdown of academic impact, for papers by Clementina Ramos Breakdown of academic impact, for papers by A. López-Alba Breakdown of academic impact, for papers by Anna Schranz Breakdown of academic impact, for papers by Sarah Biester Breakdown of academic impact, for papers by Terra Cushman Breakdown of academic impact, for papers by B. Scholz Breakdown of academic impact, for papers by Deanna Gabrielson Breakdown of academic impact, for papers by Muel Telo Muyer Breakdown of academic impact, for papers by H. Atkins
Rankless by CCL
2026